| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3946349 | Gynecologic Oncology | 2016 | 5 Pages |
Abstract
•Current FIGO classification envisages a subclassification of stage IV in IVA and IVB.•Prognostic impact of subclassification in stage IVA and IVB was evaluated.•Revised FIGO IV subclassification did not add additional prognostic information.
ObjectiveThe revised 2014 FIGO staging system for epithelial ovarian cancer (EOC) included many changes of the previous system, particularly dividing FIGO stage IV in two subgroups. We evaluated if classifying patients with EOC in FIGO stage IVA and IVB has any prognostic implication.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Beyhan Ataseven, Philipp Harter, Christoph Grimm, Florian Heitz, Sebastian Heikaus, Alexander Traut, Annett Kahl, Christian Kurzeder, Sonia Prader, Andreas du Bois,